✦ LIBER ✦

SECOND-LINE CHEMOTHERAPY WITH DOCETAXEL FOR PROSTATESPECIFIC ANTIGEN (PSA) RELAPSE IN MEN WITH HORMONEREFRACTORY PROSTATE CANCER (HRPC) PREVIOUSLY TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY

✍ Scribed by C.H. Ohlmann; E. Özgür; S. Wille; U. Engelmann; A. Heidenreich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line docetaxel and gemcitabine co

✍ Faruk Tas; Cumhur Demir; Hakan Camlica; Zeki Ustuner; Erkan Topuz 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 95 KB

Clinical outcome of patients with doceta

✍ Thomas Nelius; Tobias Klatte; Werner de Riese; Allan Haynes; Stephanie Filleur 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 201 KB

PCN17 NO CONCLUSIVE EVIDENCE FROM RANDOM

✍ M Mason; N Freemantle; A Parnaby; D Högberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Neutropenia as a Potential Pharmacodynam

✍ Gregory R. Pond; William R. Berry; Matthew D. Galsky; Brian A. Wood; Lance Leopo 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 532 KB

Response to docetaxel/carboplatin-based

✍ Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

A dose-escalation study of irinotecan (C

✍ Kakolyris, S; Souglakos, J; Agelaki, S; Kourousis, Ch; Mavroudis, D; Sarra, E; M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 66 KB